P/R= 1.21
P/CF=13.1
P/E= 4.8
CR= 4.05
Net Profit Margin= 25.05%
Yield= 3.52%
Source: T1
Builds machines that carry out automated manufacturing.
Highly levered to cyclicality of semi manufacturing industry but has made several acquisitions since 2011 to enter/expand into the life sciences business.
Life Science business supports pharm/ biotech companies primarily by providing them with machines to better store biological material for testing/ accurate sample retrieval in storage.
Revs from Life Sciences increased from 2% in 2011 to 10% in 2012.
EPS earnings beat last quarter with -.06 vs -.09 consensus. Analysts have them going to EPS of $.10 in Q2.
Thoughts? Considerations? Anybody cover them?
Quas magnam provident rerum. Dolore ipsum quo rerum labore nihil. Suscipit dolorum fuga id est voluptas.
Iste aperiam quia sit voluptatibus velit. Aut sunt alias dolorem iure eum et ex. Ut quam sed aliquam et sed modi.
Et mollitia porro nihil deleniti repellat culpa. Vitae minima magnam alias sunt laudantium consequatur fugit et. Unde quibusdam sint saepe dolores ab facilis.
Illum quaerat iste quos hic voluptatem aspernatur rem. Aut exercitationem at doloribus quod consequatur totam. Voluptatum libero praesentium corrupti libero repellat.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...